AI-powered pharma hub in TG to create 50,000 jobs

An Artificial Intelligence-powered, Hyderabad-headquartered Pulsus Group is set to create 50,000 jobs at an AI-based Pharma Healthcare IT Hub in Ameenpur, Sangareddy, Telangana, at an estimated cost of Rs 300 crore. This project will significantly impact the healthcare and IT landscape, generating economic benefits. Dr Srinubabu Gedela, CEO and Managing Director of Pulsus Group, revealed the project details at the 73rd IPC Congress, an annual event for pharmacists in Hyderabad on Friday. According to the Pulsus Group, the hub is expected to create 10,000 direct jobs and 40,000 indirect jobs through supporting industries and services. Srinubabu emphasised the transformative potential of AI, stating, “This AI-powered hub aligns with the IPC Congress theme ‘Role of Indian Pharma: For Global Wellbeing. By integrating advanced AI, we aim to streamline processes, enhance drug development precision and improve patient outcomes, positioning Telangana in the forefront of healthcare innovation in India. Key features of the project include innovative AI applications in all aspects of pharma, from research and development to healthcare delivery, generating substantial employment opportunities for local residents. The hub which is located within the designated IT/ITeS Zone in Ameenpur, benefits from exceptional infrastructure and connectivity, with support from the Telangana government and the Software Technology Parks of India. Hyderabad’s pharma industry contributes more than 40% of bulk drug production in India and is known as the “Bulk Drug Capital of India” and the “Vaccine Capital of the World.” The city’s innovation, infrastructure and inclusive growth have paid rich dividends, with Telangana ranking second in manufacturing per the Innovation Index-2022 and leading the country with the highest per-capita income in 2022-23. This AI-powered hub is set to significantly boost Telangana’s economy and healthcare sector.